ArticleJournal of stroke2014
Risk factors and biomarkers of ischemic stroke in cancer patients.
Article in Journal of stroke, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 62 citations in OpenAlex.
- Cerebrovascular and Peripheral Vascular Complications in Cancer Patients.Current neurology and neuroscience reports · 2025Review
- The impact of inflammation and iron metabolism on gene expression alterations in ischemic stroke: a bioinformatics approach.Scientific reports · 2025Article
- Nanomedicine in Management of Cerebral Infarction and Brain Cancer: Role of Inflammation.Current medicinal chemistry · 2025Review
- Ischemic Stroke with Comorbid Cancer Has Specific miRNA-mRNA Networks in Blood That Vary by Ischemic Stroke Mechanism.Annals of neurology · 2024Article
- Synthetic data in cancer and cerebrovascular disease research: A novel approach to big data.PloS one · 2024Article
- Increased risk of ischemic stroke associated with elevated gamma-glutamyl transferase level in adult cancer survivors: a population-based cohort study.Scientific reports · 2023Article
- White Embolus-induced Basilar Artery Occlusion Due to Pulmonary Vein Invasion of a Metastasis of a Malignant Melanoma.Internal medicine (Tokyo, Japan) · 2023Article
- Factors related to white thrombi in acute ischemic stroke in cancer patients.The neuroradiology journal · 2023Article
- Neurovascular Manifestations of Iron-Deficient Anemia: Narrative Review and Practical Reflections through a Teaching Case.Journal of clinical medicine · 2022Article
- In Patients with Acute Ischemic Stroke and Cancer: The Shorter Interval, the Higher D-Dimer.Asian Pacific journal of cancer prevention : APJCP · 2022Article
- Clinical characteristics and tumor markers in ischemic stroke patients with active cancer.Internal and emergency medicine · 2022Article
- Biomarkers for prognostic functional recovery poststroke: A narrative review.Frontiers in cell and developmental biology · 2022Review
- The Index of Esophageal Cancer Related Ischemic Stroke: A Retrospective Patient Control Study.Neuropsychiatric disease and treatment · 2022Article
- Effectiveness of mechanical thrombectomy in cancer-related stroke and associated factors with unfavorable outcome.BMC neurology · 2021Article
- Ischemic Stroke in Patients with Cancer: a Retrospective Cross-Sectional Study.Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures) · 2021Article
- Multiple cerebral infarction due to Trousseau's syndrome as the first manifestation of pancreatic adenocarcinoma.Acta neurologica Belgica · 2020Article
- Independent risk factors and the potential predictors of bladder cancer-related ischemic stroke.The Journal of international medical research · 2020Article
- Specific Biomarkers of Prostate Cancer-Associated Ischemic Stroke: A Case-Control Study.Medical science monitor : international medical journal of experimental and clinical research · 2019Article
- AF in Cancer Patients: A Different Need for Anticoagulation?European cardiology · 2019Review
- Active Cancer and Elevated D-Dimer Are Risk Factors for In-Hospital Ischemic Stroke.Cerebrovascular diseases extra · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background and purposeStroke is common among cancer patients. However, risk factors and biomarkers of stroke in cancer patients are not well established. This study aimed to investigate risk factors and biomarkers as well as etiology of ischemic stroke in cancer patients.
methodsA retrospective review was conducted in cancer patients with ischemic stroke who were admitted to a general hospital in Busan, Korea, between January 2003 and December 2012. The risk factors and biomarkers for stroke and stroke subtypes in cancer patients were compared with age- and sex-matched noncancer patients with ischemic stroke who were admitted to the same hospital during the same period.
resultsOne hundred fifty-six cancer patients with ischemic stroke were identified. Cancer patients with ischemic stroke were found to have a significantly lower proportion of hypertension, atrial fibrillation, hyperlipidemia, and ischemic heart disease than noncancer patients with ischemic stroke. However, stroke biomarkers, such as erythrocyte sedimentation rate and high-sensitivity C-reactive protein, fibrinogen, pro-brain natriuretic peptide, and D-dimer levels, were significantly increased in cancer patients with ischemic stroke than in noncancer patients. Large-artery atherosclerosis and stroke of undetermined cause were more common in cancer patients with ischemic stroke than in noncancer patients with ischemic stroke.
conclusionsCancer patients with ischemic stroke showed different risk factors, stroke biomarkers, and stroke etiology compared with noncancer patients with ischemic stroke.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.